Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica Spectrum Disorders”

169 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 169 results

Not applicableNot Yet RecruitingNCT06903130
What this trial is testing

Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMOSD
National and Kapodistrian University of Athens 40
Not applicableLooking for participantsNCT06312644
What this trial is testing

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Who this might be right for
Ultomiris-exposed Pregnant/ PostpartumPregnancyParoxysmal Nocturnal Hemoglobinuria (PNH)+3 more
Alexion Pharmaceuticals, Inc. 75
Early research (Phase 1)Study completedNCT04146285
What this trial is testing

A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Bio-Thera Solutions 15
Not applicableStudy completedNCT03819413
What this trial is testing

Clinical Patterns of Neuromyelitis Optica Spectrum Disorders in Assiut University Hospital

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Assiut University 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06497374
What this trial is testing

FcRn Antagonists (Efgartigimod) for Acute NMOSD Attack

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder
Tianjin Medical University General Hospital 63
Large-scale testing (Phase 3)Looking for participantsNCT05346354
What this trial is testing

Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 12
Not applicableStudy completedNCT03766347
What this trial is testing

Pediatric NMOSD Observational Study

Who this might be right for
Neuromyelitis OpticaNMO Spectrum Disorder
Mayo Clinic 100
Not applicableStudy completedNCT05871658
What this trial is testing

Efficacy of Electroacupuncture in NMOSD Patients With Pain: Study Protocol

Who this might be right for
Neuromyelitis Optica Spectrum DisordersPain
Yuanqi Zhao,MD 20
Early research (Phase 1)Study completedNCT02276963
What this trial is testing

Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Johns Hopkins University 6
Not applicableUnknownNCT05414487
What this trial is testing

Effects of Ofatumumab Treatment on Immune Cells and Meningeal Lymphatic Drainage in Patients With Demyelinating Diseases

Who this might be right for
Multiple SclerosisNeuromyelitis Optica Spectrum DisorderDemyelinating Diseases of the Central Nervous System
Tianjin Medical University General Hospital 34
Post-approval studies (Phase 4)Ended earlyNCT05269667
What this trial is testing

A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention

Who this might be right for
Neuromyelitis Optica Spectrum DisorderNMOSD
Hoffmann-La Roche 4
Testing effectiveness (Phase 2)UnknownNCT04064944
What this trial is testing

Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Third Affiliated Hospital, Sun Yat-Sen University 144
Not applicableActive Not RecruitingNCT00445367
What this trial is testing

Biobank For MS And Other Demyelinating Diseases

Who this might be right for
Multiple SclerosisTransverse MyelitisNeuromyelitis Optica+2 more
Accelerated Cure Project for Multiple Sclerosis 3,226
Not applicableUnknownNCT04822623
What this trial is testing

Imaging Evaluation of Central Nervous Autoimmune Diseases

Who this might be right for
MS (Multiple Sclerosis)NMO Spectrum Disorder
Qilu Hospital of Shandong University 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05314010
What this trial is testing

MIL62 in Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Beijing Mabworks Biotech Co., Ltd. 102
Large-scale testing (Phase 3)Study completedNCT02200770
What this trial is testing

N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
MedImmune LLC 231
Not applicableUnknownNCT05284175
What this trial is testing

Orelabrutinib in Patients With AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Peking Union Medical College Hospital 23
Testing effectiveness (Phase 2)Looking for participantsNCT06697535
What this trial is testing

Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Guangzhou JOYO Pharma Co., Ltd 35
Not applicableLooking for participantsNCT06865274
What this trial is testing

Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis.

Who this might be right for
Neuromyelitis Optica Spectrum DisordersMOGADMultiple Sclerosis
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Testing effectiveness (Phase 2)Looking for participantsNCT05549258
What this trial is testing

Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Amgen 15
Load More Results